← Open Payments lookup

MYKOL WARNER: Open Payments

NPI 1275158966 · DENVER, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$791 in 42 payments from 15 companies in 2025. Trend: 2023 $1,119 · 2024 $1,311 · 2025 $791

Food & beverage: $791
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)6$179
ABBVIE INC.15$158
Axsome Therapeutics, Inc.3$65
Collegium Pharmaceutical, Inc.3$60
Takeda Pharmaceuticals U.S.A., Inc.2$52
Lundbeck LLC2$50
Vanda Pharmaceuticals Inc.2$44
Supernus Pharmaceuticals, Inc.2$40
Otsuka Pharmaceutical Development & Commercialization, Inc.1$29
Alkermes, Inc.1$23

Products named: CAPLYTA, VRAYLAR, REXULTI, Jornay PM, TRINTELLIX, Auvelity, FANAPT, Qelbree.

Industry payments across CO — which companies pay providers there.